Pamela J Provan - The University of Sydney

基本信息

Career Trajectory

Bio

Molecular profiling of ovarian cancer

Research Interests

Papers共 33 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Molecular Pathology of Ovarian Cancer in the INOVATe Program (individualised Ovarian Cancer Treatment Through Integration of Genomic Pathology into Multidisciplinary Care)

Rosemary Balleine, Lyndal Anderson, Spinder Samra,Raghwa Sharma, King Tan,Pamela Provan,Cristina Mapagu, Natalie Bouantoun, Nikilyn Nevins,Sivatharsny Srirangan,Catherine Kennedy, Jessica Boros,Eunice Lee,Anna DeFazio

Pathology (2025): S4-S5

Cited0Views0Bibtex

8P Biomarkers to Predict Chemotherapy Response in Low-Grade Serous Ovarian Carcinoma

S. Kumari,T. Moujaber, B. Gloss, I. Madsen,B. Gao,P. Provan, S. Srirangan, N. Bouantoun, C. Kennedy,N. Traficante,M.L. Friedlander, A. Brand,C. Gourley,D.W. Garsed,D. Bowtell,P. Harnett,R. Balleine,A. Defazio

ESMO Open (2024): 103508

Cited0Views0Bibtex

Supplemental Table S1 from Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring—The TADE Study

Peter Fox, Rosemary L. Balleine,Clara Lee,Bo Gao, Bavanthi Balakrishnar, Alexander M. Menzies, Shang Heng Yeap, Sayed Sahanawaz Ali,Val Gebski,Pamela Provan, Sally Coulter,Christopher Liddle, Rina Hui,Richard Kefford,Jodi Lynch,Mark Wong,Nicholas Wilcken,Howard Gurney

openalex（2023）

Cited0Views0Bibtex

Supplemental Table S3 from Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring—The TADE Study

Peter Fox,Rosemary L. Balleine,Clara Lee,Bo Gao,Bavanthi Balakrishnar,Alexander M. Menzies, Shang Heng Yeap, Sayed Sahanawaz Ali,Val Gebski,Pamela Provan,Sally Coulter,Christopher Liddle, Rina Hui,Richard Kefford,Jodi Lynch,Mark Wong,Nicholas Wilcken,Howard Gurney

openalex（2023）

Cited0Views0Bibtex

16P Response to Taxanes in Low-Grade Serous Ovarian Cancer Patients and Cell Lines

S. Kumari,T. Moujaber, I. Madsen,B. Gao,P. Provan, S. Srirangan, N. Bouantoun, C. Kennedy, R. Sharma,S. Fereday,N. Traficante,M.L. Friedlander, A. Brand,C. Gourley,D.W. Garsed,D. Bowtell,R. Balleine,P. Harnett,A. DeFazio

ESMO Openno. 1 (2023): 101037

Cited0Views0Bibtex

Supplemental Table S2 from Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring—The TADE Study

openalex（2023）

Cited0Views0Bibtex

Supplemental Figure 1 from Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring—The TADE Study

Peter Fox,Rosemary L. Balleine,Clara Lee,Bo Gao,Bavanthi Balakrishnar, Alexander M. Menzies, Shang Heng Yeap, Sayed Sahanawaz Ali,Val Gebski,Pamela Provan,Sally Coulter,Christopher Liddle, Rina Hui,Richard Kefford,Jodi Lynch,Mark Wong,Nicholas Wilcken,Howard Gurney

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn